Tag: Combivent
Boehringer agrees to pay $13.5M to settle misleading marketing charges
The settlement, joined by all 50 states and the District of Columbia, requires the Ridgefield firm to reform its advertising practices.
BI pays $95M in whistleblower case
Boehringer Ingelheim Pharmaceuticals Inc. is paying $95 million to settle federal allegations it improperly marketed multiple drugs and paid kickbacks to doctors.